Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on ...
Bristol-Myers Squibb wants a bird’s-eye view of discoveries in cancer immunotherapy, and a few years ago launched an initiative to stay close to top academic centers working in the area. Now, it’s ...
The Bristol-Myers Squibb research complex in Wallingford, which the company plans to vacate at the end of this year. PHOTO CONTRIBUTED Drugmaker Bristol-Myers Squibb said Monday it has added Yale ...
Bristol-Myers Squibb (BMS) has acquired Cormorant Pharmaceuticals, a developer of cancer and rare-disease therapies, for up to $520 million, in a deal designed to broaden the buyer’s oncology pipeline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback